Search: 
You do not have permission to access this chart.
Please Sign Up or Login
News for Viracta Therapeutics, Inc. (VIRX)
Newly released Crypto mining rig for Viracta Therapeutics, Inc. coins
minutes ago | Banggood.com
Everything Crypto on sale now!
58 minutes ago | Aliexpress.com
Viracta Therapeutics Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
3 days ago | PRNewsWire
Viracta Therapeutics Announces FDA Clearance of IND Application for Phase 1b/2 Trial in Epstein-Barr Virus-Positive (EBV+) Solid Tumors
3 weeks ago | PRNewsWire
Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer and Key Additions to Management Team
a month ago | PRNewsWire
Viracta Therapeutics Announces its Addition to the Russell 2000® Index and other FTSE Russell Indexes
a month ago | PRNewsWire
Viracta Therapeutics Announces the Initiation of NAVAL-1, a Global Pivotal Trial for the Treatment of Relapsed/Refractory Epstein-Barr Virus-Positive Lymphoma
2 months ago | PRNewsWire
Viracta Therapeutics to Host Key Opinion Leader Webinar
2 months ago | PRNewsWire
Viracta Therapeutics Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
3 months ago | PRNewsWire
Viracta Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
4 months ago | PRNewsWire
VIRX Stock Price Increases Over 10% Pre-Market: Why It Happened
4 months ago | Pulse2

About:

Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. It is developing nanatinostat, an oral combination therapy in combination with the antiviral agent valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma. The company was founded in 2007 and is headquartered in Cardiff, California.

Sector:

Healthcare

Industry:

Biotechnology

Address:

Viracta Therapeutics, Inc. 2533 South Coast Highway 101 Suite 210 Cardiff CA 92007 United States

Website:

Home

Phone:

858-400-8470

Leave a comment

Your email address will not be published. Required fields are marked *